by | Jun 12, 2024 | Publications
Clin Exp Med. 2024 Jun 12;24(1):125. doi: 10.1007/s10238-024-01368-2. ABSTRACT PURPOSE: Despite improvements in multiple myeloma (MM) survival rates, data on cardiovascular outcomes in long-term survivors remain lacking. METHODS: This retrospective case-control study...
by | Jun 12, 2024 | Publications
OTO Open. 2024 Jun 11;8(2):e144. doi: 10.1002/oto2.144. eCollection 2024 Apr-Jun. NO ABSTRACT PMID:38863484 | PMC:PMC11165674 | DOI:10.1002/oto2.144
by | Jun 12, 2024 | Publications
Blood Cancer J. 2024 Jun 11;14(1):95. doi: 10.1038/s41408-024-01076-w. NO ABSTRACT PMID:38862493 | DOI:10.1038/s41408-024-01076-w
by | Jun 12, 2024 | Publications
Cell Commun Signal. 2024 Jun 11;22(1):320. doi: 10.1186/s12964-024-01699-3. ABSTRACT Multiple Myeloma (MM), a cancer of terminally differentiated plasma cells, is the second most prevalent hematological malignancy and is incurable due to the inevitable development of...
by | Jun 11, 2024 | Publications
Clin Nucl Med. 2024 Jun 3. doi: 10.1097/RLU.0000000000005296. Online ahead of print. ABSTRACT A 60-year-old woman underwent whole-body contrast-enhanced CT because multiple myeloma was suspected. The contrast-enhanced CT showed pancreatic enlargement without main...
by | Jun 11, 2024 | Publications
Am J Hematol. 2024 Jun 11. doi: 10.1002/ajh.27414. Online ahead of print. ABSTRACT There is growing interest in multiple myeloma (MM) circulating tumor cells (CTCs), but their rareness in peripheral blood (PB) and inconsistency in cutoffs question their clinical...